Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection

The authors formulate criteria for an optimal pre-exposure prophylaxis drug candidate, and evaluate existing antiviral drug classes for their suitability.

Detalles Bibliográficos
Autores principales: Derdelinckx, Inge, Wainberg, Mark A, Lange, Joep M. A, Hill, Andrew, Halima, Yasmin, Boucher, Charles A. B
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Policy Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1630715/
https://www.ncbi.nlm.nih.gov/pubmed/17090213
http://dx.doi.org/10.1371/journal.pmed.0030454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1630715/
https://www.ncbi.nlm.nih.gov/pubmed/17090213
http://dx.doi.org/10.1371/journal.pmed.0030454

Ejemplares similares